|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02917499 |
|
Date of registration:
|
14/09/2016 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Efficacy and Safety of TMS and Deep TMS Treatment for Psychiatric and Neurological Disorders
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
December 2016 |
|
Target sample size:
|
228 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02917499 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Investigator).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Croatia
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- diagnosed psychiatric or neurological disorder, duration of disorder for at least 5
years, inpatients or outpatients treated in Psychiatric hospital Sveti Ivan
Exclusion Criteria:
- suicidality, psychosis, alcohol addiction, unable to complete the questionnaires
Age minimum:
30 Years
Age maximum:
70 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Mood Disorders
|
|
Intervention(s)
|
|
Device: TMS
|
|
Primary Outcome(s)
|
|
the proportion of patients who experienced complete remission of the disease
[Time Frame: up to six months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|